Most Read News

Under the MoU, EIL and NRL will jointly develop and license indigenous technologies.

This is a ready-to-use insulin formulation for intravenous (IV) infusion developed by Celerity Pharmaceuticals LLC (Celerity), using Biocon Biologics' biosimilar human insulin drug substance.

With effect from 21 March 2022

With effect from 01 April 2022

The company will receive consideration of Rs43 crore in multiple tranches from the buyer, Sterlite Power Transmission.

The duo will also explore the export possibility of the products to reach out the global demands.

Government’s decision to hike gas prices will benefit upstream companies and city gas distribution companies

Here is the stock market performance at 10:30 AM today.

The company has formally closed its operation at Industrial land bearing Plot No.6, Sector-3, Industrial Estate, IMT Manesar, Gurgaon and Haryana .

The benchmark indices extended initial gains in morning trade. Barring the Nifty IT index, all the sectoral indices on NSE advanced. The Nifty hovered above 17,500 mark. At 10:30 IST, the barometer index, S&P BSE Sensex rose 231.18 points or 0.39% at 58,799.69. The Nifty 50 index gained 74.45 points or 0.43% at 17,539.20. The S&P BSE Mid-Cap index added 0.97%. The S&P BSE Small-Cap […]